The Buffett Era Is Over: Could This Ultra‑High‑Yield Stock Unravel?

Kraft Heinz reported 2025 revenue of $24.9 billion, down 3.5% for its third consecutive year of declining sales, and posted an EPS loss of $4.93, down 318%. The stock's 26%+ decline has lifted its dividend yield to about 7.28%, but the company is still battling weaker consumer demand, store-brand competition, and a $600 million turnaround investment. Berkshire Hathaway has registered its entire 326.5 million-share stake for potential sale, creating an additional overhang on investor sentiment.

Analysis

KHC is now a classic yield-supported restructuring failure: the dividend screens attractively because equity has de-rated faster than cash generation, but that same yield is doing a lot of work in masking the absence of organic growth. The key second-order issue is that a larger marketing/R&D push is inherently a margin tradeoff, so any stabilization in share can easily come with lower near-term earnings power and less room for buybacks or debt reduction.

The bigger risk is not just weak consumer demand, but brand erosion becoming structurally permanent. Once shoppers switch to private label during inflation, they often do not fully switch back; that means the company is fighting a behavioral reset, not just a temporary price gap. In that regime, trying to defend shelf space with better product innovation can be a long-cycle fix, with the first credible evidence likely taking multiple quarters rather than weeks.

Berkshire's registered stake is the most important technical overhang. Even if it never sells aggressively, the market will discount a potential distribution process and cap any multiple expansion because investors know supply could appear into rallies; that compresses upside convexity and makes the stock behave like a funded liquidation story rather than a turnaround.

The contrarian case is that the setup may be too pessimistic if management can re-accelerate at least one core brand and hold the dividend. At a 7%+ yield, the stock can trade as a bond proxy if rates fall and earnings merely stabilize, but that requires confidence the reinvestment spend converts into volume, not just higher SG&A. That makes this more of a tactical relative-value trade than a durable long thesis.

Key Decisions for Investors

• Avoid initiating new long KHC at current levels; wait for evidence of 2 consecutive quarters of stable or positive organic sales before considering entry. Risk/reward is poor until the market can underwrite earnings stability rather than yield alone.
• Pair trade: short KHC vs long a higher-quality consumer staples name with stronger pricing power and less restructuring risk over the next 3-6 months. The goal is to isolate brand/management underperformance while reducing market beta.
• If already long KHC for income, hedge with short-dated call spreads or trim into any yield-driven spike; the Berkshire overhang makes rallies vulnerable to supply and multiple compression.
• Watch for a post-spend inflection over the next 2-4 quarters: if marketing/R&D spend rises but gross margin and unit trends do not improve, consider shorting on any bounce as the turnaround thesis is failing.
• For event-driven accounts, monitor BRK.B filings and any secondary-market selling pressure in KHC over the next 1-2 months; any sign of distribution would be a catalyst to press shorts or reduce long exposure.